Growth Metrics

Teladoc Health (TDOC) Cash from Investing Activities (2016 - 2025)

Teladoc Health (TDOC) has disclosed Cash from Investing Activities for 12 consecutive years, with -$34.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 15.77% to -$34.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$266.0 million through Dec 2025, down 114.43% year-over-year, with the annual reading at -$266.0 million for FY2025, 114.43% down from the prior year.
  • Cash from Investing Activities hit -$34.3 million in Q4 2025 for Teladoc Health, up from -$48.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$2.2 million in Q2 2021 to a low of -$123.3 million in Q1 2025.
  • Historically, Cash from Investing Activities has averaged -$39.4 million across 5 years, with a median of -$36.0 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 95.15% in 2021 and later crashed 1968.13% in 2022.
  • Year by year, Cash from Investing Activities stood at -$20.1 million in 2021, then plummeted by 168.45% to -$53.9 million in 2022, then skyrocketed by 32.26% to -$36.5 million in 2023, then rose by 18.8% to -$29.6 million in 2024, then fell by 15.77% to -$34.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for TDOC at -$34.3 million in Q4 2025, -$48.7 million in Q3 2025, and -$59.7 million in Q2 2025.